NCT07491497
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07491497
Title A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors TRIANA Biomedicines, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center RECRUITING Aurora Colorado 80045 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Dana Farber Cancer Center RECRUITING Boston Massachusetts 02215 United States Details
Washington University Medical Center RECRUITING St Louis Missouri 63130 United States Details
Memorial Sloan-Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Taylor Cancer Research Center RECRUITING Maumee Ohio 43537 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field